Small Molecules as Targeted Anticancer Agents
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: 31 July 2024 | Viewed by 1044
Special Issue Editors
Interests: ruthenium(II) complexes; anticancer drugs; G-quadruplex DNA; DNA damage/repair; PI3K/AKT signal pathway
Interests: anti-cancer drugs; G-quadruplex ligands; EGFR-mutation inhibitors; Ruthenium(II) complexes; Copper(II) complexes
Interests: tumor preventing and controlling; anticancer drug screening; anti-tumor mechanism; cell signaling transduction
Special Issue Information
Dear Colleagues,
Small molecules have attracted significant attention for their success in tumor-targeting drugs in clinic. Recent efforts have facilitated the development of novel small molecules acting as potential anti-cancer drugs, and amazing progress has been made.
This Special Issue welcomes all research on small molecules as promising anti-tumor agents, including works that are concerned with the design, synthesis and characterization of small molecules, such as organic and inorganic compounds and metallic complexes; in vitro and in vivo anticancer activity against varied tumor cells; the inhibitory effect on the migration and metastasis of various tumor cells, toxicity and multidrug resistance; and the underlying mechanisms of DNA damage/repair, apoptosis, autophagy and ferroptosis; the mechanisms of signaling pathway regulation; the interactions of small molecules with biology macro-molecules; goal verification; and so on.
Prof. Dr. Wenjie Mei
Dr. Qiong Wu
Dr. Jin-lan Meng
Dr. Chengxi Wang
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- small molecules
- anticancer
- inhibitor
- target
- signal pathway
- DNA damage/repair
